# CytomX to Receive $5 Million From Regeneron for Cancer Drug Milestone

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/60046
Published: 2026-11-18T02:12:42.000Z
Updated: 2026-11-18T02:12:42.000Z
Section: Business

> The payment is tied to a preclinical milestone in the companies’ cancer drug development partnership.

CytomX Therapeutics, Inc. announced that it will receive $5 million from Regeneron after reaching a preclinical milestone in their cancer drug development partnership.


